ArticleNPJ precision oncology2026

CD22-targeted immunotherapy for B-cell acute lymphoblastic leukemia progressing following CD19-targeted immunotherapy.

Fengmei Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.